A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy
Guntupalli, S.R., Brennecke, A., Sheeder, J., Cheng, G., Behbakht, K., Babayan, L.M., Corr, B.R., Lefkowits, C., Matsuo, K., Flink, D.M.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.136
Date:
June, 2017
File:
PDF, 110 KB
english, 2017